UFP Technologies Inc UFPT
What the 10-K filed Feb 27, 2026 says off the balance sheet
10-K notesRisks that are not on the face of the balance sheet. Tickdelta picks sentences with specifics and quotes them as filed. New marks a sentence with nothing like it in the 10-K filed Mar 3, 2025.
Big customers
Customers the company names as a large share of revenue or receivables (it must name any worth 10% of revenue).
“Our top ten customers represented approximately 68.8%, 68.1%, and 59.3% of our total net sales in 2025, 2024, and 2023, respectively.”
68.8% in the 10-K filed 2026-02-27, 68.1% in the one filed 2025-03-03
Read it in the 10-K
New “Two customers (Intuitive Surgical SARL and Stryker) comprised approximately 24.3% and 21.5%, respectively, of our net sales for the year ended December 31, 2025; two customers (Intuitive Surgical SARL and Stryker) comprised approximately 29.2% and 15.4%, respectively, of our net sales for the year ended December 31, 2024; one customer comprised approximately 28.1% of our net sales for the year ended December 31, 2023.”
24.3% in the 10-K filed 2026-02-27
Read it in the 10-K
New “One customer represented approximately 32.1% of gross accounts receivable for the year ended December 31, 2025, and one customer represented approximately 34.0% of gross accounts receivable for the year ended December 31, 2024.”
32.1% in the 10-K filed 2026-02-27
Read it in the 10-K
“Our net sales to customers outside the U.S., which accounted for approximately 16.0%, of net sales for 2025, and our operations in Ireland, Mexico, Central America and the Caribbean are and could be subject to a number of risks and potential costs, including:”
16% in the 10-K filed 2026-02-27, 16.7% in the one filed 2025-03-03
Read it in the 10-K
Key suppliers
Parts or manufacturing that depend on one or a few suppliers.
“In addition, we are dependent on a relatively small number of suppliers for cross-linked foam, thermoformed plastic urethane and technical polyurethane foams.”
Read it in the 10-K
Lawsuits and legal claims
Pending cases, settlements and what the company has set aside for them.
No specific sentence about this in the 10-K.
Guarantees and indemnities
Promises to pay someone else's debts or losses if they cannot.
“At December 31, 2025, we had approximately $135.5 million in outstanding borrowings under the Third Amended and Restated Credit Agreement, and also had approximately $0.7 million in standby letters of credit outstanding, drawable as a financial guarantee on worker’s compensation insurance policies.”
Read it in the 10-K
Debt covenants
Conditions in loan agreements that, if broken, can make debt due early.
“Under the Third Amended and Restated Credit Agreement, we are subject to a minimum fixed-charge coverage financial covenant as well as a maximum total funded debt to EBITDA financial covenant.”
Read it in the 10-K
“At December 31, 2025, the weighted average interest rate was approximately 5.1% and we were in compliance with all covenants under the Third Amended and Restated Credit Agreement.”
Read it in the 10-K
Commitments off the balance sheet
Contracts the company must pay for later: purchase obligations, take-or-pay deals.
No specific sentence about this in the 10-K.
Companies it names
Tracked companies that its latest 10-K or its 8-Ks of the last year call a customer or a supplier.
No other tracked company is named as a customer or a supplier in the latest filings.
Companies that name it
Tracked companies whose latest 10-K or 8-Ks call it a customer or a supplier.
No other tracked company names it as a customer or a supplier in the latest filings.
Sentences are chosen by their words, not read by AI, so some can be off topic. Always check the filing. Open the 10-K
Sources
The notes to the financial statements, Legal Proceedings and the MD&A of the latest 10-K (and, for customers and suppliers, Business and Risk Factors), quoted as filed.
Also
Debt: the debt note in numbers.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UFPT/export.csv") into a cell.